(ILIU) (ILIU) Stock Price, News & Analysis

Company Overview

Interleukin Genetics, Inc. develops and markets genetic tests for chronic diseases and health-related conditions. The Company operates through the genetic test business segment. The Company's products include PerioPredict genetic test and Inherent Health line of genetic tests. PerioPredict is a genetic risk test that analyzes genetic variations associated with inflammation and identifies individuals with a life-long predisposition to over-produce inflammation. PerioPredict identifies specific polymorphisms (genetic variations) in genes that regulate the production of interleukin-1 cytokines. PerioPredict identifies adults at increased risk for severe periodontal disease. The Company markets additional genetic tests through its Inherent Heath brand. Its additional genetic tests include weight management genetic test, bone health genetic test, heart health genetic test, nutritional needs genetic test and wellness select genetic test.

Key Stats

• Today's Range: $0.0040 to $0.0045
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.14
• Volume: 26,317 shs
• Average Volume: 91,936 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ILIU Stock Analysis - Frequently Asked Questions

How were (ILIU)'s earnings last quarter?

(ILIU) (OTCMKTS:ILIU) announced its quarterly earnings data on Friday, May, 12th. The company reported ($0.01) earnings per share for the quarter. The firm earned $0.20 million during the quarter.

What other stocks do shareholders of (ILIU) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that (ILIU) investors own include Capricor Therapeutics (CAPR), Esports Entertainment Group (GMBL), Cheniere Energy (LNG), Atlas Energy Group (ATLS), Autohome (ATHM), ASML (ASML) and Arotech (ARTX).

Company Calendar

• Last Earnings: 5/12/2017
• Today: 7/26/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ILIU
• CIK: 1037649
• Web: ilgenetics.com
• Phone: +1-781-3980700
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A